Product Information

CIMETIDINE 800 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7435 per EA under NDC 00093830501. Its NADAC has been published 644 times since Nov 28, 2013.

FDA first approved this application on May 17, 1994. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Cimetidine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CIMETIDINE 800 MG TABLET

Cimetidine
$0.7435per EA
Low Outlier

Strength

800 mg/1

NDC

00093830501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CIMETIDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA074463

FDA Approved

5/17/1994

TE Code

AB

On Market Since

12/6/2003

Pharmacological Classes

Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist

Price Statistics

The NADAC for CIMETIDINE 800 MG TABLET has been published 644 times since Nov 28, 2013, and over the history we have for it it has risen 53.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7435 per EA
All-time high$1.1403 (Feb 10, 2016)
All-time low$0.4692 (May 21, 2014)
52-week high$0.8963
52-week low$0.7435
Median price$0.8870
Average price$0.8796
Largest weekly change+30.1% (Jul 22, 2015)
Weeks tracked644
Tracking sinceNov 28, 2013

Price History

1W

-3.9%

1M

-3.9%

3M

-4.4%

6M

-8.5%

1Y

-17.1%

3Y

-24.2%

5Y

-14.5%

All

+53.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cimetidine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CIMETIDINE 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CIMETIDINE 800 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7435 per EA (NDC 00093830501), effective Aug 19, 2026.

How has the price of CIMETIDINE 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for CIMETIDINE 800 MG TABLET has risen 53.1%. It has been tracked across 644 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CIMETIDINE 800 MG TABLET?

Since Nov 28, 2013, the NADAC for CIMETIDINE 800 MG TABLET has ranged from a low of $0.4692 (May 21, 2014) to a high of $1.1403 (Feb 10, 2016), with a median of $0.8870 per EA.

Are there cheaper alternatives to CIMETIDINE 800 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CIMETIDINE 800 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CIMETIDINE 800 MG TABLET?

CIMETIDINE 800 MG TABLET (NDC 00093830501) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.